Cardiometabolic risk factors and antithrombotic treatment in a Mexican population with atrial fibrillation and heart failure with reduced ejection fraction.

Manuel A Baños-González,Antonio González-Hermosillo,Milton E Guevara-Valdivia,Jorge A Vázquez-Acosta, Manuel O de Los Ríos-Ibarra, Julio A Aguilar-Linares,Carlos Cantú-Brito,José L Leiva-Pons,Gerardo Pozas-Garza,Eddie A Favela-Pérez,Luis Molina,Reynaldo Magaña-Magaña,Rocío Camacho-Casillas,Eduardo Chuquiure-Valenzuela, Janneth Manzano-Cabada, Manlio F Márquez-Murillo

Gaceta medica de Mexico（2023）

引用 0|浏览8

暂无评分

摘要

Significant differences were found according to gender in patients with NVAF and HFrEF, both in CMRF and some comorbidities, as well as in antithrombotic treatment according to embolic and bleeding risk.

查看译文

关键词

Anticoagulantes,Anticoagulants,Atrial fibrillation,Factores de riesgo,Fibrilación auricular,Heart failure,Insuficiencia cardiaca,Mexico,México,Risk factors

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要